- Home
- VC vs DNLI Comparison
VC vs DNLI Comparison
Compare VC & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VC
- DNLI
- Stock Information
- Founded
- VC 2000
- DNLI 2013
- Country
- VC United States
- DNLI United States
- Employees
- VC N/A
- DNLI N/A
- Industry
- VC Auto Parts:O.E.M.
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VC Consumer Discretionary
- DNLI Health Care
- Exchange
- VC Nasdaq
- DNLI Nasdaq
- Market Cap
- VC 2.0B
- DNLI 1.9B
- IPO Year
- VC 2000
- DNLI 2017
- Fundamental
- Price
- VC $84.43
- DNLI $13.24
- Analyst Decision
- VC Buy
- DNLI Strong Buy
- Analyst Count
- VC 13
- DNLI 15
- Target Price
- VC $98.92
- DNLI $33.85
- AVG Volume (30 Days)
- VC 284.2K
- DNLI 1.3M
- Earning Date
- VC 07-24-2025
- DNLI 05-06-2025
- Dividend Yield
- VC N/A
- DNLI N/A
- EPS Growth
- VC N/A
- DNLI N/A
- EPS
- VC 10.69
- DNLI N/A
- Revenue
- VC $3,867,000,000.00
- DNLI N/A
- Revenue This Year
- VC N/A
- DNLI N/A
- Revenue Next Year
- VC $3.80
- DNLI $256.73
- P/E Ratio
- VC $7.90
- DNLI N/A
- Revenue Growth
- VC N/A
- DNLI N/A
- 52 Week Low
- VC $65.10
- DNLI $10.57
- 52 Week High
- VC $117.94
- DNLI $33.33
- Technical
- Relative Strength Index (RSI)
- VC 54.99
- DNLI 41.80
- Support Level
- VC $83.91
- DNLI $12.86
- Resistance Level
- VC $86.13
- DNLI $13.77
- Average True Range (ATR)
- VC 1.82
- DNLI 0.75
- MACD
- VC -0.36
- DNLI -0.11
- Stochastic Oscillator
- VC 28.34
- DNLI 14.07
About VC Visteon Corporation
Visteon Corp is an automotive supplier. It manufactures electronics products for original equipment vehicle manufacturers including Ford, Nissan, Renault, Mazda, BMW, General Motors, and Honda, etc. The company offers information displays, instrument clusters, head-up displays, infotainment systems, telematics solutions, and Smartcore. The Company's reportable segment is Electronics. The Electronics segment provides vehicle cockpit electronics products to customers, including digital instrument clusters, domain controllers with integrated driver assistance systems, displays, Android-based infotainment systems, and battery management systems. Geographically, it operates in North America, Europe, China, Asia-Pacific, and South America and Others.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.